IP Library Granted Patent US 7,658,706
Granted Patent B2
US 7,658,706 · App. 11/634,436 · Granted Feb 9, 2010

Vascular graft sterilization and decellularization

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,658,706
App. No.
11/634,436
Granted
Feb 9, 2010
Kind
B2
Abstract

The present technology is related to the field of sterilization and decellularization of allografts or xenografts, specifically to processes that achieve effective removal of the cells contained within a vascular tissue matrix and an effective reduction in potential harmful organisms to create grafts suitable for human implantation. In some embodiments, vascular grafts, vascular tissue and/or blood vessels are contacted with cleaning solution under conditions suitable conditions to reduce immune reaction in patients. More specifically, the present technology is directed to sterilization and decellularization of vascular grafts.

Claims (16)

1. A process for making a vascular graft more suitable for implantation into a recipient, the process comprising:

(a) contacting a vascular graft with an oxidizing sterilant; and

(b) contacting the vascular graft with a cleaning solution;

wherein during either step (a) or (b) or both,

a pressure gradient in the range of from about 100 mm Hg to about 400 mm Hg across a wall of said vascular graft is maintained by the flow of said cleaning solution or said oxidizing sterilant through said vascular graft;

wherein the contacting steps are at a temperature less than about 45° C. and for a total contact time less than about 8 hours; and

wherein the vascular graft comprises allograft or xenograft vascular tissue.

2. The process of claim 1 , wherein the steps are performed in the order (a), then (b).

3. The process of claim 1 , wherein a decellularized graft is produced.

4. The process of claim 1 , wherein the oxidizing sterilant is selected from the group consisting of peroxides, oxides, hypochlorites, ozone and percarboxylic acids; or mixtures thereof.

5. The process of claim 1 , wherein the oxidizing sterilant is a percarboxylic acid selected from the group consisting of peracetic acid, perpropionic acid, perbutyric acid, peroctanoic acid, perglycolic acid, perglutaric acid, persuccinic acid, perlactic acid, percitric acid and perdecanoic acid; or mixtures thereof.

6. The process of claim 1 , wherein the oxidizing sterilant is peracetic acid.

7. The process of claim 1 , wherein the cleaning solution is selected from the group consisting of solutions of cholate, alcohol ethoxylates, alkylphenol ethoxylates, alkyl polyglycosides, polyoxyethylene ethers, polyoxyethylene sorbitans, any of the Triton, Tween or Brij series of detergents, alkyl benzenesulfonates, alkyl sulfonates, alkyl phosphates, and alkyl sulfates; or salts or mixtures thereof.

8. The process of claim 1 , wherein the cleaning solution is a solution of cholate.

9. The process of claim 1 , wherein during either step (a) or (b) or both, the vascular graft is submerged in solution.

10. The process of claim 1 , wherein said pressure gradient results in mass transport by fluid convection and/or diffusion through said wall of said vascular graft.

Assignments (17)
SECURITY INTEREST Recorded Sep 25, 2025
From: RTI SURGICAL, INC.; COOK BIOTECH INCORPORATED; TISSX, LLC
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 072924/0721 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Sep 25, 2025
From: ARES CAPITAL CORPORATION
To: RTI SURGICAL INC. D/B/A EVERGEN
Reel/Frame 072938/0203 →
SECURITY INTEREST Recorded Jul 21, 2020
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL (UNITED STATES), INC.
To: ARES CAPITAL CORPORATION, AS SECURITY AGENT
Reel/Frame 053273/0665 →
RELEASE OF SECURITY INTEREST Recorded Jul 21, 2020
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
Reel/Frame 053260/0398 →
INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT Recorded Jul 20, 2020
From: SURGALIGN SPINE TECHNOLOGIES, INC. (FORMERLY KNOWN AS RTI SURGICAL, INC.)
To: RTI OEM, LLC
Reel/Frame 053259/0019 →
CHANGE OF NAME Recorded Jul 20, 2020
From: RTI OEM, LLC
To: RTI SURGICAL, INC.
Reel/Frame 053259/0146 →
CHANGE OF NAME Recorded Jul 20, 2020
From: RTI SURGICAL, INC.
To: SURGALIGN SPINE TECHNOLOGIES, INC.
Reel/Frame 053248/0432 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: ARES CAPITAL CORPORATION, AS AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
Reel/Frame 053257/0652 →
SECURITY INTEREST Recorded Mar 8, 2019
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048543/0505 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.
Reel/Frame 046327/0184 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.
Reel/Frame 046327/0864 →
SECURITY INTEREST Recorded Jun 6, 2018
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS THE ADMINISTRATIVE AGENT
Reel/Frame 046303/0926 →
SECURITY INTEREST Recorded Aug 20, 2017
From: RTI SURGICAL, INC.
To: TD BANK, N.A.
Reel/Frame 043608/0874 →
CHANGE OF NAME Recorded Aug 14, 2013
From: RTI BIOLOGICS, INC.
To: RTI SURGICAL, INC.
Reel/Frame 031012/0159 →
SECURITY AGREEMENT Recorded Jul 26, 2013
From: RTI SURGICAL, INC.
To: TD BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 030888/0001 →
CHANGE OF NAME Recorded Mar 26, 2008
From: REGENERATION TECHNOLOGIES, INC.
To: RTI BIOLOGICS, INC.
Reel/Frame 020690/0942 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2007
From: SQUILLACE, DONNA
To: REGENERATION TECHNOLOGIES, INC.
Reel/Frame 018821/0778 →